Evidence map›Paper›PMID 32737324›Full record

Observational studyNPJ primary care respiratory medicine2020

Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study.

Paula Ribó, Jesús Molina, Myriam Calle, Luis Maiz, Carlos Campo, Paula Rytilä, Vicente Plaza, Antonio Valero

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in NPJ primary care respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paula RibóAllergology Section, Pulmonology and Allergy Department, Hospital Clínic de Barcelona, Barcelona, Spain. ribo@clinic.cat.ORCID http://orcid.org/0000-0002-9129-5347
Jesús MolinaFamily Medicine Department, Centro de Salud Francia, Fuenlabrada, Madrid, Spain.ORCID http://orcid.org/0000-0002-4716-3152
Myriam CallePulmonology Departament, Hospital Clínico San Carlos, Madrid, Spain.ORCID http://orcid.org/0000-0002-3890-2742
Luis MaizPulmonology Department, Hospital Ramón y Cajal, Madrid, Spain.
Carlos CampoOrion Pharma, Madrid, Spain.
Paula RytiläOrion Corporation Orion Pharma, Espoo, Finland.
Vicente Plaza *Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-2567-5496
Antonio Valero *Allergology Section, Pulmonology and Allergy Department, Hospital Clínic de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several modifiable factors leading to poor asthma control have been described. We aimed to determine the proportion of patients with inadequate treatment, adherence to it, or critical mistakes with inhaler technique, and their impact on asthma control. We conducted a cross-sectional multicenter observational study including asthma patients referred from primary to specialist care for the first time. Data collected were adequate prescription according to guidelines, treatment adherence, and disease control. Of the 1682 patients (age 45 ± 17 years, 64.6% men), 35.9% showed inadequate prescription, 76.8% low adherence, and 17% critical mistakes with inhaler technique, with significantly less critical mistakes among Easyhaler users versus other dry powder inhaler users (10.3 versus 18.4%; p < 0.05). Factors related to bad asthma control were inadequate prescription (OR: 3.65), non-adherence to treatment (OR: 1.8), and inhaler misuse (OR: 3.03). A higher number of risk factors were associated with a higher probability of having badly controlled asthma.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Asthmatic AgentsAsthmaCross-Sectional StudiesDrug MonitoringDry Powder InhalersFemaleHumansMaleMiddle AgedNebulizers and VaporizersPrevalenceRisk FactorsAnti-Asthmatic Agents

Identifiers

PMID32737324
PMCPMC7395116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.